UA96754C2 - Композиции в виде сухого порошка и системы для вакцинации домашней птицы - Google Patents

Композиции в виде сухого порошка и системы для вакцинации домашней птицы

Info

Publication number
UA96754C2
UA96754C2 UAA200812168A UAA200812168A UA96754C2 UA 96754 C2 UA96754 C2 UA 96754C2 UA A200812168 A UAA200812168 A UA A200812168A UA A200812168 A UAA200812168 A UA A200812168A UA 96754 C2 UA96754 C2 UA 96754C2
Authority
UA
Ukraine
Prior art keywords
dry powder
poultry
powder compositions
systems
vaccination
Prior art date
Application number
UAA200812168A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Жан Поль РЕМОН
Крис ВЕРВАТ
Эви Корбани
Эк Йоханнес Хубертус Хенрикус Ван
Вильхельмус Йоханнес Матернус Ландман
Original Assignee
Университейт Гент
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Университейт Гент filed Critical Университейт Гент
Publication of UA96754C2 publication Critical patent/UA96754C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
UAA200812168A 2006-03-15 2007-03-15 Композиции в виде сухого порошка и системы для вакцинации домашней птицы UA96754C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06005245A EP1834651A1 (en) 2006-03-15 2006-03-15 Compositions and methods for veterinary vaccination

Publications (1)

Publication Number Publication Date
UA96754C2 true UA96754C2 (ru) 2011-12-12

Family

ID=37564170

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200812168A UA96754C2 (ru) 2006-03-15 2007-03-15 Композиции в виде сухого порошка и системы для вакцинации домашней птицы

Country Status (14)

Country Link
US (2) US20090041852A1 (enExample)
EP (2) EP1834651A1 (enExample)
JP (1) JP2009529558A (enExample)
CN (1) CN101415437A (enExample)
BR (1) BRPI0708983A2 (enExample)
DK (1) DK1993605T3 (enExample)
ES (1) ES2389864T3 (enExample)
MX (1) MX2008011701A (enExample)
PL (1) PL1993605T3 (enExample)
PT (1) PT1993605E (enExample)
RU (1) RU2450828C2 (enExample)
SI (1) SI1993605T1 (enExample)
UA (1) UA96754C2 (enExample)
WO (1) WO2007104562A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
PL2105129T3 (pl) 2008-03-24 2018-04-30 Intervet International B.V. Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
EP2352516A2 (en) * 2008-09-26 2011-08-10 Auburn University Immunization of avians by mucosal administration of non-replicating vectored vaccines
US9610343B2 (en) 2009-05-20 2017-04-04 Aeras Global Tb Vaccine Foundation Stable, spray dryed, immunogenic, viral compositions
JP5550277B2 (ja) * 2009-07-23 2014-07-16 長谷川香料株式会社 保存安定性に優れた粉末組成物
UA110328C2 (en) * 2009-08-21 2015-12-25 Merial Ltd Recombinant vaccine based on avian paramixoviruses and method for its preparation and administration
US20130071421A1 (en) * 2009-10-02 2013-03-21 W. Ian Lipkin Turkey viral hepatitis virus and uses thereof
CN102772799A (zh) * 2012-05-31 2012-11-14 郑州后羿制药有限公司 一种鸭病毒性肝炎、鸭瘟二联卵黄抗体冻干粉及其制备方法
CN103083659B (zh) * 2013-01-18 2015-05-13 北京华夏兴洋生物科技有限公司 新型无油佐剂制备方法及用途
WO2018050873A1 (en) 2016-09-16 2018-03-22 Leukocare Ag A novel method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation
WO2018050872A1 (en) * 2016-09-16 2018-03-22 Leukocare Ag A novel method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
CN107019707A (zh) * 2017-03-14 2017-08-08 杨凌绿方生物工程有限公司 一种鸡胚成纤维细胞产品冻干工艺方法
TR201718859A2 (tr) * 2017-11-27 2017-12-21 Bilge Kaan Tekelioglu Siğirlarin gangrenli̇ nezlesi̇ i̇çi̇n aşi ve aşinin üreti̇m yöntemi̇
CN109260467B (zh) * 2018-08-17 2021-08-20 山东信得科技股份有限公司 一种预防雏鹅痛风症状的疫苗
EP3698773A1 (en) 2019-02-21 2020-08-26 Università degli Studi di Parma Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination
CN113599513A (zh) * 2020-10-23 2021-11-05 青岛大学 一种适用于咽喉部接种的新型冠状病毒疫苗的制备方法及接种方法
AU2022398370A1 (en) * 2021-11-25 2024-05-30 Orexo Ab Pharmaceutical composition comprising biopharmaceutical drug compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58105310U (ja) * 1982-01-11 1983-07-18 貝原　睦衛 ひよこ用ワクチン点眼装置
JPS5924019U (ja) * 1982-08-05 1984-02-15 イカリ消毒株式会社 動物用ワクチン投与装置
RU2035909C1 (ru) * 1993-06-02 1995-05-27 Виноходов Владимир Олегович Препарат для профилактики и лечения заболеваний птиц
GB9607035D0 (en) * 1996-04-03 1996-06-05 Andaris Ltd Spray-dried microparticles as therapeutic vehicles
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
US6651655B1 (en) * 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
AU2003221888B2 (en) * 2002-04-11 2008-11-06 Medimmune, Llc Preservation of bioactive materials by spray drying
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
KR20100107083A (ko) * 2002-12-17 2010-10-04 메디뮨 엘엘씨 생물활성 물질의 고압 분무 건조
US20050207983A1 (en) * 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
JP2008505192A (ja) * 2004-06-14 2008-02-21 メッドイミューン バクシーンズ，インコーポレイティド 生物活性材料の高圧噴霧乾燥
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination

Also Published As

Publication number Publication date
EP1993605A1 (en) 2008-11-26
RU2008140745A (ru) 2010-04-20
PL1993605T3 (pl) 2012-12-31
WO2007104562A1 (en) 2007-09-20
US20110150940A1 (en) 2011-06-23
BRPI0708983A2 (pt) 2011-06-21
CN101415437A (zh) 2009-04-22
PT1993605E (pt) 2012-09-17
MX2008011701A (es) 2008-11-27
DK1993605T3 (da) 2012-09-10
ES2389864T3 (es) 2012-11-02
EP1993605B1 (en) 2012-06-27
SI1993605T1 (sl) 2012-11-30
JP2009529558A (ja) 2009-08-20
US20090041852A1 (en) 2009-02-12
RU2450828C2 (ru) 2012-05-20
EP1834651A1 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
UA96754C2 (ru) Композиции в виде сухого порошка и системы для вакцинации домашней птицы
WO2009073508A3 (en) Polysaccharide gel compositions and methods for sustained delivery of drugs
PH12017500778A1 (en) COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
WO2007090127A3 (en) Compressible intravascular embolization particles and related methods and delivery systems
NZ600640A (en) Abuse-resistant formulations
MY148405A (en) Immunogenic composition
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
EP2481409A3 (en) Nanoparticle comprising rapamycin and albumin as anticancer agent
JP2014240439A5 (enExample)
EP1786400A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOLOGICAL ACTIVE SUBSTANCES
SG10201804552WA (en) Nanoparticle compositions, formulations thereof, and uses therefor
NZ594024A (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
WO2011019956A3 (en) Pharmaceutical compositions with tetrabenazine
MX2012000035A (es) Antigenos de virus de sincicio respiratorio recombinantes.
WO2009135190A3 (en) Therapeutic calcium phosphate particles and methods of making and using same
WO2011057225A3 (en) Self-assembled particles from zwitterionic polymers and related methods
JP2009529558A5 (enExample)
EP2395048A3 (en) Polymers compositions including an antioxidant
UA103179C2 (ru) Фармацевтическая композиция, которая содержит эзетимиб
WO2006122223A3 (en) Strategies for delivery of active agents using micelles and particles
MX2009008487A (es) Picoplatino encapsulado.
GB201200858D0 (en) Prebiotic powder composition and uses thereof
MY147485A (en) Improvements in or relating to compositions, articles and methods
TW200727925A (en) Air treatment compositions and devices therefor
WO2011039629A3 (es) Fracción bioactiva de petiveria alliacea, composición farmacéutica que la contiene y combinación con agentes inmunoestimulantes para el tratamiento del cáncer